Elmiron is used to treat patients with Interstitial Cystitis (IC), which is an ailment in the urinary tract system/bladder. IC causes pain and is a chronic condition that causes frequent urination that mostly affects women. Janssen Pharmaceuticals a division of Johnson & Johnson had known for over 20 years and failed to warn patients about the potential eye damage risks that are associated with taking Elmiron.
Recent studies have shown that patients who have been prescribed Elmiron may have developed Maculopathy, an eye disorder that can lead to blindness. Maculopathy is an eye disorder affecting the central part of the retina associated with highly sensitive vision. Symptoms for patients experiencing damage from taking Elmiron include:
- Blindness
- Blurred vision
- Difficulty reading
- Difficulty adapting to dim lighting
- Dark spots in the center of vision
- Straight lines appearing curved or squiggly
- Muted, less vivid colors
INSERRA l KELLEY l SEWELL wants you and yours to know that if you have suffered side effects from Elmiron, please consult with your physician to find out if you should immediately stop taking the medication.
If you or a loved one suffered from severe side effects or blindness from Elmiron, please call the mass tort Team at Inserra Kelley Sewell to see whether you might be entitled to compensation.